COMMUNIQUÉS West-GlobeNewswire

The Pennant Group Announces Public Offering of Common Stock
30/09/2024
EAGLE, Idaho, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced that it has commenced an underwritten public offering of 3,500,000 shares of common stock of the [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30/09/2024
WATERTOWN, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
30/09/2024
– Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic lupus erythematosus – – Mary Beth Harler, M.D., [...]
Galapagos receives transparency notification from EcoR1 Capital
30/09/2024
Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian transparency [...]
Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
30/09/2024
NEWTON, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers [...]
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024
30/09/2024
NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today [...]
Laguna Treatment Center Expands Offerings with Equine Therapy and Breathwork
30/09/2024
ALISO VIEJO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Laguna Treatment Center, a leading Southern California-based addiction treatment facility, has expanded its treatment options to include breathwork and equine [...]
AB Science announces a slight delay in the publication of its 2024 half-year financial report
30/09/2024
PRESS RELEASE AB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2024 HALF-YEAR FINANCIAL REPORT THE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2024 ON OCTOBER 7, 2024 Paris, September 30 2024, 6 [...]
AB Science annonce un léger décalage de la publication de son rapport financier du premier semestre 2024
30/09/2024
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE UN LEGER DECALAGE DE LA PUBLICATION DE SON RAPPORT FINANCIER SEMESTRIEL 2024 LA SOCIETE PUBLIERA SON RAPPORT FINANCIER SEMESTRIEL 2024 LE 7 OCTOBRE 2024 Paris, 30 septembre 2024, [...]
Eurobio Scientific : COMMUNIQUÉ DU 30 SEPTEMBRE 2024 EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE EUROBIO SCIENTIFIC S.A. INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT
30/09/2024
COMMUNIQUÉ DU 30 SEPTEMBRE 2024 RELATIF AU DÉPÔT DU PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ Eurobio Scientific EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE EUROBIO SCIENTIFIC S.A. [...]
EB DEVELOPMENT : COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
30/09/2024
COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ Eurobio Scientific INITIÉE PAR EB DEVELOPMENT AGISSANT DE CONCERT AVEC IK X LUXCO 3 S.A R.L, [...]
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
30/09/2024
Company announcement – No. 46 / 2024 Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Copenhagen, Denmark, September 30, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. [...]
Penn Medicine, Rockefeller Neuroscience Institute and Precision Neuroscience Unveil Breakthrough Neural Implant Data at the 2024 Congress of Neurological Surgeons Annual Meeting
30/09/2024
First-of-its-kind in-human studies reveal unprecedented detail in brain signal mapping, advancing brain-computer interface technology NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Today, researchers from the Perelman [...]
Instinct Report: Morale is Trending Up in 2024, but Employee Turnover Remains High in ER & Specialty Hospitals
30/09/2024
PHILADELPHIA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Instinct Science, a leading technology provider for veterinary hospitals, today announced its second annual State of Emergency and Specialty Veterinary Care Report. Based [...]
Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year
30/09/2024
Global investigative sites recognize Parexel’s commitment to strong site relationships and patients DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations ( [...]
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30/09/2024
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Android smartwatches. [...]
AssureCare Welcomes Stacy Mountain as Vice President of Sales
30/09/2024
CINCINNATI, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of Population Health Management solutions, is proud to welcome Stacy Mountain as the new Vice President of Sales. Stacy will lead the [...]
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
30/09/2024
Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programs HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage [...]
Drs. Javier, Perez, and Roth Collaborate with Castle Connolly Private Health Partners to Create Joint Concierge Program, Precision Concierge Physicians
30/09/2024
Precision Concierge Physicians — for patients who desire a personalized approach to their healthcare NAPLES, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Castle Connolly Private Health Partners, LLC (CCPHP), a leader in [...]

Pages